Sam Neill’s Rare Lymphoma: Clinical Trials Show Promise

One study targets Epstein-Barr virus commonly found in patients with aggressive T-cell subtype

In a forthcoming memoir, actor Sam Neill of “Jurassic Park” fame reveals that he’s been battling angioimmunoblastic T-cell lymphoma, also known as AITL.

The aggressive form of blood cancer was diagnosed at stage 3, meaning it had spread throughout the actor’s lymphatic system. He told The Guardian newspaper that he underwent chemotherapy and is currently on a new chemotherapy drug that has put him in remission.

Video: AITL Update

Brad Haverkos, MD, associate professor of medicine-hematology

at the CU School of Medicine and member of the CU Cancer Center,

gave a talk about AITL to the Lymphoma Research Foundation last year.

Watch it here.

Neill, who also stars in the Netflix series “Peaky Blinders” and performed in the Oscar-winning film “The Piano,” is 75 and lives in his native New Zealand.

In the following Q&A, Brad Haverkos, MD, associate professor of medicine-hematology at the University of Colorado School of Medicine and member of the CU Cancer Center, talks about this rare form of lymphoma and research being conducted at CU Anschutz into potentially promising new therapies for AITL.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.